Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis

BACKGROUND: The aim of this study was to assess the cost-effectiveness of administering magnesium sulphate to patients in whom preterm birth at < 32(+0) weeks gestation is either imminent or threatened for the purpose of fetal neuroprotection. METHODS: Multiple decision tree models and probabilis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bickford, Celeste D, Magee, Laura A, Mitton, Craig, Kruse, Marie, Synnes, Anne R, Sawchuck, Diane, Basso, Melanie, Senikas, Vyta M, von Dadelszen, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878233/
https://www.ncbi.nlm.nih.gov/pubmed/24350635
http://dx.doi.org/10.1186/1472-6963-13-527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878233/
https://www.ncbi.nlm.nih.gov/pubmed/24350635
http://dx.doi.org/10.1186/1472-6963-13-527

Ejemplares similares